Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hypotension × imisopasem manganese × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Dermatologic 1

Conditions

Pain 1 Neoplasms 1 Melanoma 1 Hypotension 1 Carcinoma, Renal Cell 1

Interventions

Norepinephrine 2 imisopasem manganese 1 dopexamine 1 Vasoconstrictor Agents 1 Tea 1 Phenylephrine 1 Levobupivacaine 1 Epinephrine 1 Dobutamine 1 Catecholamines 1 Anesthesia, General 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00033956 2005-06-24

Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2

MetaPhore Pharmaceuticals

Phase 1/2 Suspended

DermatologicGenitourinary

Carcinoma, Renal Cell, Hypotension, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡